Your current location :Home > English > Press Releases >

On August 27, 2018, the Shanghai Food and Drug Administration approved the application for the relocation of phenobarbital tablets production, agreed its production address moved from No. 1888 Zhuxin Road, Jinshan Industrial Area to No. 428 Xihan Road, Fengxian District, Shanghai.

This approval is another milestone before CCP starts its official production. We will continue to strive for GMP certificate and make contributions to the development of China's pharmaceutical industry!